ARTICLE | Financial News
Abgenix slips on ABX-IL8 news
May 15, 2002 7:00 AM UTC
ABGX was off $0.40 to $14.71 on 7.8 million shares on Wednesday. On Tuesday after market close, the company said it is discontinuing development of its ABX-IL8 human monoclonal antibody against IL-8 f...